MedTrace Logo

CT (Computerized Tomography) for Late EndovasculAr Reperfusion

NCT04096248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2790

Last updated 2024-06-04

No results posted yet for this study

Summary

The objective of this multicenter, retrospective, cross-sectional, chart review study is to compare outcomes (disability, complications and mortality) of patients with large vessel occlusion stroke presenting at late time window selected by either Non-Contrast CT (NCCT) only, advanced imaging with CTP (Computed Tomography Perfusion), MRI (Magnetic Resonance Imaging), or medical management.

Boston Medical Center (BMC) will serve as the main data coordinating site. Fifteen additional sites will seek local IRB approval or ethics approval. The aggregated de-identified data will be analyzed comparing types of interventions and outcomes by type of imaging or medical management.

Conditions

  • Stroke, Cardiovascular

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Society of Vascular and Interventional Neurology

    collaborator UNKNOWN

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Thanh Nguyen, MD · Boston Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-15
Primary Completion
2021-05-23
Completion
2022-05-01

Countries

  • United States
  • Belgium
  • Canada
  • Finland
  • France
  • Germany
  • Japan
  • Portugal
  • Spain
  • Switzerland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04096248 on ClinicalTrials.gov